logo

GUFICBIO vs VIYASH: Stock Comparison

GUFIC BIOSCIENCES vs VIYASH SCIENTIFICUpdated 22 Oct 26, 4:08 PM ISTNSE & company filings

VIYASH SCIENTIFIC is the larger company by market capitalisation. GUFIC BIOSCIENCES shows a higher ROE, a higher dividend yield and faster revenue growth, while VIYASH SCIENTIFIC shows a lower P/E and lower leverage. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

GUFICBIO leads 8; VIYASH leads 3 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

GUFICBIOVIYASH

Valuation lens

What price are you paying?

Market CapContext only
₹3,948 Cr
₹9,199 Cr
P/E RatioVIYASH has the lower reading
53.78x
49.82x ✓
P/B RatioVIYASH has the lower reading
5.94x
3.12x ✓
EPSGUFICBIO has the higher reading
₹2.22 ✓
₹1.51
Book ValueContext only
₹66.31
₹71.3
Dividend YieldGUFICBIO has the higher reading
0.03% ✓
0%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
VIYASH is the larger company
₹9,199 Cr vs ₹3,948 Cr
P/E Ratio
VIYASH has a lower P/E
49.82x vs 53.78x
P/B Ratio
VIYASH has a lower P/B
3.12x vs 5.94x
EPS
GUFICBIO has higher earnings per share
₹2.22 vs ₹1.51
Dividend Yield
GUFICBIO has a higher dividend yield
0.03% vs 0%
Revenue Growth (TTM YoY)
GUFICBIO has faster revenue growth
22.8% vs 0%
EPS Growth (TTM YoY)
GUFICBIO has faster EPS growth
183.1% vs 0%
ROE
GUFICBIO has a higher ROE
9.66% vs 7.21%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricGUFICBIOVIYASH
SectorHealthcare—
IndustryPharmaceuticals—

Price

MetricGUFICBIOVIYASH
Live Price₹394₹207.99
Day Change1.16%-2.62%
Volume1.11 L21.17 L
52-Week High₹467.8₹298
52-Week Low₹268₹178.13
Distance from 52W High-15.78%-30.2%

Valuation

MetricGUFICBIOVIYASH
Market Cap₹3,948 Cr₹9,199 Cr
P/E Ratio53.78x49.82x
P/B Ratio5.94x3.12x
EPS₹2.22₹1.51
Book Value₹66.31₹71.3
Dividend Yield0.03%0%

Growth

MetricGUFICBIOVIYASH
Revenue Growth (TTM YoY)22.8%0%
EPS Growth (TTM YoY)183.1%0%
Qtr Sales Growth0%0%
Qtr Profit Growth0%0%

Profitability & Leverage

MetricGUFICBIOVIYASH
ROE9.66%7.21%
ROCE9.25%8.17%
Net Margin6.8%6.57%
Operating Margin13.05%12.23%
Debt to Equity0.58x0.14x

Shareholding

As of Sep 2026 • change vs previous quarter
MetricGUFICBIOVIYASH
Promoter Holding72.5%0%
FII Holding0.45%▼ 0.01 pp2.6%▼ 1.9 pp
DII Holding3.38%▼ 0.3 pp8.3%▲ 4.55 pp
Public Holding23.67%▲ 0.31 pp39.76%▲ 9.42 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: GUFIC BIOSCIENCES and VIYASH SCIENTIFIC.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.